TABLE 3. C-6 Elaborated DHPMs from the Metalation
red color was quenched in most of the cases, indicating the
consumption of the carbanion. Stirring was continued for ad-
ditional time (Table 2) to complete the reaction, after which a
saturated aqueous solution of NH4Cl was introduced. The
reaction was treated with brine and extracted with ethyl acetate
(3 × 25 mL). The extracts were dried over anhydrous Na2SO4,
and the mixture was concentrated under reduced pressure. The
products were isolated using flash chromatography using silica
gel-G (60-120 mesh) and mixtures of ethyl acetate/hexane as
eluent. For preparing samples for microanalytical analysis,
crystallization was done using a combination of dry DCM and
hexane or methanol and petroleum ether (entries 3-7; Table
2). The characteristic data of the selected compounds are
presented below.
of 1c-f
isolated
yield (%)
entry
DHPM 1
R5
product
1
2
3
4
1c
1d
1e
1f
4-OMe-C6H4
3r
3s
3t
65
78
72
67
3,4,5-tri(OMe)C6H2
H
Et
3u
Entry 7, Table 1. 5-Ethoxycarbonyl-6-propyl-4-phenyl-
3,4-dihydropyrimidin-2(1H)-one (3b): Creamy white solid;
Rf: 0.5 (30% v/v ethyl acetate/hexane); yield 71%; mp 162-165
°C (DCM); IR (KBr): νmax 3245, 1705, 1665 cm-1 1H NMR
;
mercaptopropyl substituent followed by reaction with di-
n-propyldisulfide. However, in the reaction of diphenyl-
disulfide, C-6 di-substituted DHPM 3n (entry 9, 35%) was
formed exclusively.
The hard electrophile n-propionyl chloride furnished
only N-3 substituted product 3o (entry 10, Table 2) in
60% yield. Likewise, reaction of ethyl formate with the
anion of 1a furnishes N-3 formylated product 3p (entry
11), exclusively. The formation of N-3 acylated DHPMs,
otherwise tedious to synthesize,12a is prized for their
special biological effects.12b Trimethylsilyl chloride
quenched the anion of 1a to furnish the C-6 elaborated
DHPM 3q (entry 12, 75%) exclusively.
To further explore the scope of this methodology, we
performed metalation reactions of various C-4 aryl as
well as alkyl substituted Biginelli substrates with LDA
(4.1 equiv), using ethyl bromide as electrophile (0 °C)
using the standardized procedure. The corresponding C-6
elaborated products were obtained in a synthetically
useful manner (Table 3).
In summary, DHPM derivatives readily undergo vi-
nylogous metalation at the C-6 position with alkyllithium
bases. The resulting anion intermediates can be treated
with a variety of electrophilic reagents to afford impor-
tant C-6 elaborated DHPMs in modest to good yields.14
This methodology permits a variety of electrophilic
functionalities to be introduced at the C-6 methyl position
of variously C-4 substituted DHPMs.
(CDCl3): δ 0.95 (t, 3H, J 7.2 Hz), 1.15 (t, 3H, J 6.9 Hz), 1.62 (m,
2H), 2.66 (m, 2H), 4.06 (q, 2H, J 7.0 Hz), 5.37 (d, 1H, J 3 Hz),
6.43 (br, 1H, NH, exchanged with D2O), 7.25 (m, 5H), 8.68 (br,
1H, NH, exchanged with D2O); 13C NMR (CDCl3): δ 13.7, 14.0,
21.6, 26.8, 33.3, 55.3, 59.8, 100.8, 126.4, 127.7, 128.5, 143.8,
150.6, 153.8, 165.3; Anal. Required for C16H20N2O3: C, 66.65;
H, 6.99; N, 9.72; Found: C, 66.88; H, 6.53; N, 9.65; MS: m/z
288 (M+).
Entry 4, Table 2.5-Ethoxycarbonyl-6-(2-hydroxy-2-meth-
yl-propyl)-4-phenyl-3,4-dihydropyrimidin-2(1H)-one (3i):
White solid; Rf: 0.4 (65% ethyl acetate/hexane); yield: 38%; mp
160-162 °C (methanol); IR (KBr): νmax 3480, 3260, 1695, 1635
1
cm-1; H NMR (CDCl3): δ 1.14 (t, 3H, J 7.2 Hz), 1.33 (s, 3H,),
1.35 (s, 3H), 2.72 (s, 1H), 3.08 (ABq, 2H, J 79.8 Hz, J 14.4 Hz),
4.05 (q, 2H, J 7.2 Hz), 5.42 (d, 1H, J 2.7 Hz), 5.51 (br, 1H, NH,
exchanged with D2O), 7.32 (m, 5H), 8.06 (br, 1H, NH, exchanged
with D2O); 13C NMR (CDCl3): δ 14.0, 29.6, 30.1, 41.3, 56.0, 60.1,
71.8, 73.6, 103.0, 126.6, 127.9, 128.7, 143.7, 147.9, 152.4, 165.9,
and 175.8; Anal. Required for C17H22N2O4: C, 64.13; H, 6.97;
N, 8.80; Found: C, 64.12; H, 6.58; N, 8.55; MS: m/z 318 (M+).
Entry 4, Table 2. 7,7-Dimethyl-4-phenyl-3,4,7,8-tetrahy-
dro-1H-pyrano[4,3-d]pyrimidine-2,5-dione (4a): White solid;
Rf: 0.6 (70% ethyl acetate/hexane); yield: 35%; mp 240 °C
(methanol); IR (KBr): νmax 3274, 1710, 1664 cm-1 1H NMR
;
(CDCl3 + DMSO-d6): δ 1.22 (s, 3H), 1.37 (s, 3H), 2.47 (ABq, 2H,
J 64.2 Hz, J 17.7 Hz), 5.29 (d, 1H J 3.6 Hz) 6.96 (br, 1H, NH,
exchanged with D2O), 7.21 (m, 5H), 9.47 (br, 1H, NH, exchanged
with D2O); 13C NMR (CDCl3 + DMSO-d6): δ 25.9, 28.0, 35.6,
53.4, 97.4, 126.0, 127.2, 128.0, 128.1, 143.0, 145.9, 152.0, and
163.5. Anal. Required for C15H16N2O3: C, 66.16; H, 5.92; N,
10.29; Found: C, 65.82; H, 5.90; N, 9.93; MS: m/z 272 (M+).
Entry 5, Table 2. 7-Benzyl-7-methyl-4-phenyl-3,4,7,8-
tetrahydro-1H-pyrano[4,3-d]pyrimidine-2,5-dione (4c, Ma-
jor Diastereomer): White solid; Rf: 0.5 (80% ethyl acetate/
hexane); yield: 60%; mp 232 °C (ethanol); IR (KBr): νmax 3404,
1693, 1674 cm-1; 1H NMR (CDCl3 + DMSO-d6): δ 1.26 (s, 3H),
2.54 (ABq, 2H, J 74.7 Hz, J 17.4 Hz), 2.98 (m, 2H), 5.19 (d, 1H,
J 1.8 Hz), 7.25 (m, 10H), 7.61 (br, 1H, NH, exchanged with D2O),
Experimental Section
Typical Procedure for C-6 Alkylation of 5-Ethoxycarbon-
yl-6-methyl-4-phenyl-3,4-dihydro-2(1H)-pyrimidinone 1a.
To a suspension of DHPM 1a (1.3 g, 5 mmol) in 10 mL of dry
THF under a blanket of dry N2, LDA (4 equiv in 37 mL of dry
THF) was added dropwise through a cannula at -10 °C. After
the addition, the reaction mixture was warmed to room tem-
perature and stirred for an additional 3 h until blood red colored
carbanion was generated. To this carbanion, the appropriate
electrophile (3.0 equiv), dissolved in 10 mL of dry THF, was
added dropwise. Upon addition of the electrophile (Table 2), the
9.52 (br, 1H, NH, exchanged with D2O); 13C NMR (CDCl3
+
DMSO-d6): 23.4, 29.3, 32.2, 45.2, 52.2, 78.2, 95.7, 125.0, 125.3,
125.9, 126.6, 126.8, 129.1, 134.2, 145.6, 150.2, and 162.0; Anal.
Required for C21H20N2O3: C, 72.40; H, 5.79; N, 8.04; Found: C,
72.84; H, 5.28; N, 7.83. MS: m/z 349 (M+).
Entry 6, Table 2. 5-Ethoxycarbonyl-6-[2-hydroxy-2-(4-
nitro-phenyl)ethyl]-4-phenyl-3,4-dihydropyrimidin-2(1H)-
one (3j, Major Diastereomer): Dark yellow crystalline solid;
Rf: 0.4 (70% ethyl acetate/hexane); yield: 58%; mp 202 °C
(ethanol); IR (KBr): νmax 3577, 3371, 3220, 1697, 1685 cm-1; 1H
NMR (CDCl3 + DMSO-d6): δ 1.12 (t, 3H, J 7.07 Hz), 3.17 (ABX
system, 2H, J 13.5 Hz, J 9.2 Hz, J 2.8 Hz), 4.03 (q, 2H, J 7.1
Hz), 5.14 (dd, 1H, J 9.2 Hz, J 2.8 Hz), 5.25 (m, 1H, OH,
exchanged with D2O), 5.35 (d, 1H, J 2.4 Hz), 6.40 (br, 1H, NH,
exchanged with D2O), 7.31 (m, 5H), 7.67 (d, 2H, J 8.5 Hz), 8.17
(d, 2H, J 8.53 Hz), 8.94 (br, 1H, NH, exchanged with D2O); 13C
NMR (CDCl3 + DMSO-d6): δ 13.7, 55.1, 59.8, 72.0, 101.3, 123.1,
126.1, 126.2, 126.4, 127.4, 128.3, 143.8, 146.6, 148.1, 152.0, 152.2,
(12) (a) Atwal, K. S.; Rovnyak, G. C.; O’Reilly, B. C.; Schwartz, J.
J. Org. Chem. 1989, 54, 5898. (b) Atwal, K. S.; Swanson, B. N.; Unger,
S. E.; Floyd, D. M.; Moreland, S.; Hedberg, A.; O’Reilly, B. C. J. Med.
Chem. 1991, 34, 806.
(13) Eynde, J. J. V.; Audiart, N.; Canonne, V.; Michel, S.; Haverbeke,
Y. V.; Kappe, C. O. Heterocycles 1997, 45, 1967.
(14) The structures of all compounds were supported by 300 MHz
1H and 75 MHz 13C NMR and mass spectra. All compounds gave a
single spot on TLC analysis and correct micro analytical data (see
Supporting Information).
6116 J. Org. Chem., Vol. 70, No. 15, 2005